Journal of Pediatric Hematology/Oncology · 2021 · 40 citations · 32 references
MedicineChild HealthPediatricsEarly DetectionPediatric HematologyPediatric NeurologyCerebrovascular DiseasePediatric StrokePopulation ScreeningScreening EvaluationSickle Cell DiseaseStrokePediatric Stroke PreventionPopulation Screening For HemoglobinopathiesPrimary Stroke PreventionSickle Cell AnemiaSickle Cell Disease-associated StrokeSickle Cell Disease-related StrokeSickle Cell Trait ScreeningStroke Risk Stratification
Stroke prevention guidelines for sickle cell anemia (SCA) recommend transcranial Doppler (TCD) screening to identify children at stroke risk; however, TCD screening implementation remains poor. This report describes results from Part 1 of the 28-site DISPLACE (Dissemination and Implementation of Stroke Prevention Looking at the Care Environment) study, a baseline assessment of TCD implementation rates. This report describes TCD implementation by consortium site characteristics; characteristics of TCDs completed; and TCD results based on age. The cohort included 5247 children with SCA, of whom 5116 were eligible for TCD implementation assessment for at least 1 study year. The majority of children were African American or Black, non-Hispanic and received Medicaid. Mean age at first recorded TCD was 5.9 and 10.5 years at study end. Observed TCD screening rates were unsatisfactory across geographic regions (mean 49.9%; range: 30.9% to 74.7%) independent of size, institution type, or previous stroke prevention trial participation. The abnormal TCD rate was 2.9%, with a median age of 6.3 years for first abnormal TCD result. Findings highlight real-world TCD screening practices and results from the largest SCA cohort to date. Data informed the part 3 implementation study for improving stroke screening and findings may inform clinical practice improvements.
32
Robert J. Adams, Lewis L. Hsu, Elliott Vichinsky et al. · New England Journal of Medicine · 1998 · 1.9K citations · Full text
Medicine, Hematology, Pediatrics +10
Cerebrovascular accidents in sickle cell disease: rates and risk factors.
Kwaku Ohene‐Frempong, Steven J. Weiner, Lynn A. Sleeper et al. · PubMed · 1998 · 1.7K citations
Michael R. DeBaun, Lori C. Jordan, Allison A. King et al. · Blood Advances · 2020 · 417 citations · Full text
Medicine, Hematology, Pediatrics +17
Stroke Prevention Trial in Sickle Cell Anemia (STOP): extended follow-up and final results
Margaret T. Lee, Sergio Piomelli, Suzanne Granger et al. · Blood · 2006 · 321 citations · Full text